Kaleido Biosciences, Inc.·4

Oct 19, 7:37 AM ET

Menichella Daniel L 4

4 · Kaleido Biosciences, Inc. · Filed Oct 19, 2020

Insider Transaction Report

Form 4
Period: 2020-10-15
Menichella Daniel L
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-10-15+600,000600,000 total
    Exercise: $8.69Exp: 2030-10-14Common Stock (600,000 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest on October 15, 2021, with the remainder vesting in 12 equal quarterly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION